IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been selected as the winner of the “Best Mobile App for Patient Engagement” in the ninth-annual MedTech Breakthrough Awards program.

IQVIA’s breakthrough Health Research Space platform allows direct-to-patient data collection and engagement with patient-facing mobile apps that helps patients and their caregivers participate in decentralized clinical trials around the world. The platform is configurable, multilingual and compatible with web, iOS and Android and is available across many geographic regions, increasing patient access to participate in clinical research.

The app improves trial participant engagement and retention and includes robust privacy and security features. By facilitating direct-to-patient data collection, the platform helps to generate real-world evidence for new medicines and innovative medical devices and diagnostics.

"IQVIA’s mobile app is essential for improving engagement and reaching patients and caregivers. It lets them connect from any location, essentially meeting them where they are, with strong patient privacy safeguards," said Rob Kotchie, president of Real World Solutions at IQVIA. "Our platform meets the needs of real-world decentralized and hybrid studies throughout the drug and device development life cycle, helps to reduce patient burden and enables long-term follow-up. It ensures that patients can participate in studies more easily and for extended periods.”

The MedTech Breakthrough Awards, a program of Tech Breakthrough, an independent market intelligence organization, recognizes excellence and innovation in the health and medical technology industry. The program honors the companies, products and solutions driving meaningful progress and improving patient care. This year’s program received 4,500 entries across all awards, showcasing the global impact and momentum of the digital healthcare industry today.

“There’s a growing expectation for life sciences organizations to focus on patient-centered and long-term outcome data collection,” said Steve Johansson, managing director, Tech Breakthrough. “However, traditional clinical study participation is not possible for all patient populations and includes barriers, such as the need to travel to a research site for in-person appointments. IQVIA’s innovative patient-facing app helps reduce barriers to patient participation and provides effective, efficient data collection and engagement. Its streamlined processes make it easy for individuals to engage and take a more active role in managing their health. Congratulations to the IQVIA team on recognition of this solution.”

To learn more about the IQVIA Health Research Space solution, visit our site.

About IQVIA

IQVIA (NYSE: IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

About the MedTech Breakthrough Awards

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical and health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information, visit MedTechBreakthrough.com.

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250616756204/en/